Literature DB >> 19889771

Modification of small hepatitis delta virus antigen by SUMO protein.

Chung-Hsin Tseng1, Tai-Shan Cheng, Chiung-Yueh Shu, King-Song Jeng, Michael M C Lai.   

Abstract

Hepatitis delta antigen (HDAg) is a nuclear protein that is intimately involved in hepatitis delta virus (HDV) RNA replication. HDAg consists of two protein species, the small form (S-HDAg) and the large form (L-HDAg). Previous studies have shown that posttranslational modifications of S-HDAg, such as phosphorylation, acetylation, and methylation, can modulate HDV RNA replication. In this study, we show that S-HDAg is a small ubiquitin-like modifier 1 (SUMO1) target protein. Mapping data showed that multiple lysine residues are SUMO1 acceptors within S-HDAg. Using a genetic fusion strategy, we found that conjugation of SUMO1 to S-HDAg selectively enhanced HDV genomic RNA and mRNA synthesis but not antigenomic RNA synthesis. This result supports our previous proposition that the cellular machinery involved in the synthesis of HDV antigenomic RNA is different from that for genomic RNA synthesis and mRNA transcription, requiring different modified forms of S-HDAg. Sumoylation represents a new type of modification for HDAg.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19889771      PMCID: PMC2798338          DOI: 10.1128/JVI.01034-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1.

Authors:  M Gostissa; A Hengstermann; V Fogal; P Sandy; S E Schwarz; M Scheffner; G Del Sal
Journal:  EMBO J       Date:  1999-11-15       Impact factor: 11.598

Review 2.  Papillomaviruses and the host SUMOylation system.

Authors:  Y-C Wu; A F Deyrieux; V G Wilson
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

Review 3.  SUMO-specific proteases: a twist in the tail.

Authors:  Ronald Thomas Hay
Journal:  Trends Cell Biol       Date:  2007-09-04       Impact factor: 20.808

4.  Transcription of subgenomic mRNA of hepatitis delta virus requires a modified hepatitis delta antigen that is distinct from antigenomic RNA synthesis.

Authors:  Chung-Hsin Tseng; King-Song Jeng; Michael M C Lai
Journal:  J Virol       Date:  2008-07-23       Impact factor: 5.103

5.  p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53.

Authors:  Stephanie Carter; Karen H Vousden
Journal:  Cell Cycle       Date:  2008-08-09       Impact factor: 4.534

6.  Cell biology: SUMO.

Authors:  Erik Meulmeester; Frauke Melchior
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

7.  Characterization of the phosphorylated forms and the phosphorylated residues of hepatitis delta virus delta antigens.

Authors:  J J Mu; H L Wu; B L Chiang; R P Chang; D S Chen; P J Chen
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25.

Authors:  Erik Meulmeester; Marion Kunze; He Hsuan Hsiao; Henning Urlaub; Frauke Melchior
Journal:  Mol Cell       Date:  2008-06-06       Impact factor: 17.970

9.  Differential regulation of the two transcriptional activation domains of the coiled-coil coactivator CoCoA by sumoylation.

Authors:  Catherine K Yang; Jeong Hoon Kim; David K Ann; Michael R Stallcup
Journal:  BMC Mol Biol       Date:  2008-01-25       Impact factor: 2.946

Review 10.  Sumoylation regulates diverse biological processes.

Authors:  J Zhao
Journal:  Cell Mol Life Sci       Date:  2007-12       Impact factor: 9.261

View more
  22 in total

Review 1.  Hepatitis delta virus: A fascinating and neglected pathogen.

Authors:  Celso Cunha; João Paulo Tavanez; Severin Gudima
Journal:  World J Virol       Date:  2015-11-12

2.  Modification of nonstructural protein 1 of influenza A virus by SUMO1.

Authors:  Ke Xu; Christoph Klenk; Bin Liu; Bjoern Keiner; Jinke Cheng; Bo-Jian Zheng; Li Li; Qinglin Han; Chen Wang; Tianxian Li; Ze Chen; Yuelong Shu; Jinhua Liu; Hans-Dieter Klenk; Bing Sun
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

3.  Molecular and clinical aspects of hepatitis D virus infections.

Authors:  Elham Shirvani Dastgerdi; Ulf Herbers; Frank Tacke
Journal:  World J Virol       Date:  2012-06-12

Review 4.  Life cycle and pathogenesis of hepatitis D virus: A review.

Authors:  Zaigham Abbas; Rafia Afzal
Journal:  World J Hepatol       Date:  2013-12-27

5.  The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus.

Authors:  Chung-Yi Wu; King-Song Jeng; Michael M-C Lai
Journal:  J Virol       Date:  2011-04-20       Impact factor: 5.103

6.  SUMO1 Modification Facilitates Avibirnavirus Replication by Stabilizing Polymerase VP1.

Authors:  Huansheng Wu; Hui Yang; Gang Ji; Tuyuan Zheng; Yina Zhang; Tingjuan Deng; Xiaojuan Zheng; Jiyong Zhou; Boli Hu
Journal:  J Virol       Date:  2019-05-01       Impact factor: 5.103

Review 7.  Hepatitis D Virus Replication.

Authors:  John M Taylor
Journal:  Cold Spring Harb Perspect Med       Date:  2015-11-02       Impact factor: 6.915

8.  Rotavirus viroplasm proteins interact with the cellular SUMOylation system: implications for viroplasm-like structure formation.

Authors:  Michela Campagna; Laura Marcos-Villar; Francesca Arnoldi; Carlos F de la Cruz-Herrera; Pedro Gallego; José González-Santamaría; Dolores González; Fernando Lopitz-Otsoa; Manuel S Rodriguez; Oscar R Burrone; Carmen Rivas
Journal:  J Virol       Date:  2012-10-31       Impact factor: 5.103

9.  Sumoylation at the host-pathogen interface.

Authors:  Van G Wilson
Journal:  Biomolecules       Date:  2012-04-05

10.  The human cytomegalovirus DNA polymerase processivity factor UL44 is modified by SUMO in a DNA-dependent manner.

Authors:  Elisa Sinigalia; Gualtiero Alvisi; Chiara V Segré; Beatrice Mercorelli; Giulia Muratore; Michael Winkler; He-Hsuan Hsiao; Henning Urlaub; Alessandro Ripalti; Susanna Chiocca; Giorgio Palù; Arianna Loregian
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.